Precision Health Care for All: The University of Arizona Health Sciences Center for Advanced Molecular and Immunological Therapies

Health Sciences Education Building 435 N 5th St, Phoenix, AZ, United States

Michael D. Dake, MD, senior vice president for the University of Arizona Health Sciences, will introduce a new Phoenix-based research center that will accelerate the development and availability of personalized cell and gene-based therapies, and serve as the hub of a new innovation district at the downtown Phoenix Bioscience Core.

AZBioPEERS: Tales from the Road

Virtual

Featured Speaker: Tassos, CEO, MyoKardia who will share his journey from conception to acquisition.

Myths, Stigmas, and Barriers in LGBTQ+ Health

Virtual

Myth or Fact? “Straight” people don’t have to worry about HIV infection.

This is a myth. Misinformation about LGBTQ+ health issues contributes to biases against the community, creates confusion over important health questions, and can even prevent some from seeking health care when needed. The more we know about our health, the more empowered we can become to make informed health decisions that affect us daily. Join us as we confront, dispel, and correct common LGBTQ+ health myths and discuss what everyone can do to help eradicate barriers to inclusive medical treatment and ensure representation in health research for all.

AZBioPEERS: Tales From The Road

Virtual

Please join us as Tassos discusses his journey from conception to acquisition. MyoKardia was acquired in 2020 by Bristol Myers Squibb for $13.1 Billion in Cash.